Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levobupivacaine for Postoperative Pain in Pediatric Hernia Repair
NCT04869046Phase 4Completed
- Sponsor
- Mother and Child Health Institute of Serbia Dr Vukan Čupić
- Start
- Mar 2013
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of levobupivacaine in postoperative pain, sponsored by Mother and Child Health Institute of Serbia Dr Vukan Čupić. Primary endpoints: Postoperative pain assessment at 6 hours and Analgesic efficacy of nonopioid analgesic mixture at 24 hours. Started Mar 2013; status: completed.
02
Drugs
levobupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04869046.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04869046.